Should I continue allopurinol 100 mg daily given a serum uric acid of 6.2 mg/dL and no gout flares?

Increase Allopurinol Dose to Achieve Target Serum Uric Acid

Yes, you should increase the allopurinol dose because a serum uric acid of 6.2 mg/dL is above the recommended target of <6.0 mg/dL, and current guidelines strongly recommend dose titration to achieve this target. 1, 2

Target Serum Uric Acid Level

The FDA label explicitly states that allopurinol should be titrated "until a serum uric acid level of 6 mg/dL or less is attained," with the upper limit of normal being approximately 7 mg/dL for men and postmenopausal women, and 6 mg/dL for premenopausal women. 2 Your current level of 6.2 mg/dL exceeds this target.

The 2020 American College of Rheumatology guidelines strongly recommend starting with low-dose allopurinol (≤100 mg/day) and performing subsequent dose titration to reach target serum uric acid levels. 1 This is exactly your current situation—you started appropriately at 100 mg daily, but now need to titrate upward.

Recommended Titration Strategy

Increase allopurinol by 100 mg increments at weekly intervals until serum uric acid reaches <6.0 mg/dL. 2

• The FDA label recommends increasing by 100 mg weekly intervals, with the maximal recommended dosage being 800 mg daily. 2
• Research demonstrates that a single 100 mg dose increase produces a mean fall in uric acid of approximately 71 µmol/L (about 1.2 mg/dL), and 65% of patients achieve target after just one 100 mg uptitration. 3
• In your case, increasing from 100 mg to 200 mg daily would likely bring your uric acid below 6.0 mg/dL.

Why Absence of Flares Doesn't Mean Adequate Treatment

The absence of gout flares does not indicate adequate urate-lowering therapy. 1, 2

• Maintaining serum uric acid above target allows continued urate crystal deposition in tissues and joints, perpetuating the disease process even without acute symptoms. 1
• The goal of urate-lowering therapy is to dissolve existing urate deposits and prevent new crystal formation, which requires achieving and maintaining serum uric acid <6.0 mg/dL. 2

Flare Prophylaxis During Dose Escalation

Continue or initiate anti-inflammatory prophylaxis (colchicine, NSAIDs, or low-dose prednisone) during dose titration. 1, 2

• The ACR guidelines strongly recommend continuing prophylaxis for 3-6 months, with ongoing evaluation if flares persist. 1
• The FDA label warns that acute gout attacks may increase during early allopurinol therapy, even when normal serum uric acid levels are attained, due to mobilization of urates from tissue deposits. 2
• Prophylaxis should continue until serum uric acid has been normalized and there has been freedom from acute attacks for several months. 2

Safety of Dose Escalation

Allopurinol dose escalation is safe and well-tolerated. 4, 5

• The LASSO study of 1,732 patients found that 20.2% received doses >300 mg daily with no new safety signals, and rash incidence was only 1.5% overall. 4
• A 24-month extension study demonstrated that the majority of patients tolerate higher than creatinine clearance-based allopurinol doses and achieve target serum uric acid. 5
• Treatment-emergent adverse events possibly related to allopurinol occurred in only 11.4% of patients receiving >300 mg doses. 4

Expected Outcome

Research shows that 97% of patients who undergo appropriate allopurinol uptitration achieve target uric acid levels, with a median final dose of 300 mg daily. 3 Recent comparative effectiveness data from a 940-patient trial demonstrated that 80% of participants achieved target urate levels with dose-titrated allopurinol. 6